The Latest Breaking News from Moderna

Booster jabs provide up to 70 per cent protection, study finds

Say hello to Ms Novavax!

Turkish daily death toll highest in four months as cases surge; UK health agency says number of cases each day could be rising

Europe could enter ‘long period of Covid tranquility’ due to high vaccination rates, WHO says; record 1.33 million UK long Covid patients

Here's everything you need to know about vaccination status and testing process in countries such as France, Austria, Switzerland and Italy

A whale with a lot of money to spend has taken a noticeably bullish stance on Moderna. Looking at options history for Moderna (NASDAQ:MRNA) we detected 10 strange trades.

A new study from the Center for Disease Control and Prevention confirms what Mayo Clinic and other experts have been saying: COVID-19 booster vaccinations improve protection against severe illness and hospitalization. The study examined people who had three doses of the Moderna or Pfizer COVID-19 vaccines, as well as whether…

WASHINGTON — Moderna Inc.’s vaccine for COVID-19 received full approval from the U.S. Food and Drug Administration for people 18 and older, an important milestone that bolsters the shot’s use as a major weapon against the virus.

Moderna Inc (NASDAQ: MRNA) is trading higher Monday after the U.S. Food and Drug Administration approved the Biologics License Application for SPIKEVAX to prevent COVID-19 in individuals 18 years of age and older.